Conclusion
EVENTS, SECONDARY
Patients with elevated cTnT one year after MI, PCI and/or CABG had decreased composite endpoint-free and crude survival, and a smaller proportion in this group were on ASA treatment. Assessment of Troponin T in secondary preventive follow-up after coronary heart events might identify patients at high risk and might contribute to optimizing of the secondary preventive treatment, as well as further refinement of cardiovascular risk prediction tools.